Objective: The aim of the present study was to evaluate the association of obesity and diabetes with 18F-FDG PET/CT SUVmax values and metastasis in breast cancer patients. Material and Methods: The study included 126 breast cancer patients who underwent 18F-FDG PET/CT for staging between 2023 and 2024. Results: There was no significant correlation between the presence of obesity and breast tumour SUVmax value (p=0.427). There was no significant relationship between body mass index and metastatic lymph node SUVmax and distant metastasis SUVmax (p=0.06, p=0.457). There was no significant association between the presence or absence of diabetes and distant metastasis SUVmax or lymph node metastasis SUVmax on 18F-FDG PET/CT (p=0.723, p=0.581). In our study, there was no significant difference in the 18F-FDG PET/CT findings of breast cancer patients with diabetes at the time of diagnosis compared to women without diabetes. In addition, although not statistically significant, we found that the median SUVmax values for lymph node and distant metastases were significantly higher in obese and morbidly obese patients compared to other patients. Therefore, we think that breast cancer patients should be followed up more closely in the follow-up of obese and diabetic patients, taking these conditions into consideration and patients should be advised to lose weight. Conclusion: In conclusion, although we did not find a significant association between body mass indeks and diabetes and breast cancer in our study, we think that this may be due to the small number of patients. We also found that the risk of axillary lymph node metastasis increased as breast tumor SUVmax increased and the cut-off value for breast tumor SUVmax was 5.15. We think that the presence of lymph node metastasis on PET/CT should be reported carefully, taking into account the SUVmax value.
23 February 2024 in Molecular Imaging and Radionuclide Therapy
Objectives: This study aimed to evaluate the relationship between mobile phone usage and miRNA-574-5p and miRNA-30C-5p levels in patients diagnosed with differentiated thyroid cancer (DTC). Methods: Fifty patients diagnosed with DTC and 50 healthy volunteers were included in the study. miRNA-574-5p and miRNA-30C-5p gene expression levels in the blood of all subjects were analyzed by real time-polymerase chain reaction, and a questionnaire including various questions was administered to both groups. Results: Although there was a 7.60 -fold increase in miRNA-30C-5p gene expression levels in the patient group compared with the control group, it was not found to be statistically significant. Considering the miRNA-574-5p gene expression levels, although there was a 2.96 -fold increase in the patient group compared with the control group, no significant relationship was found. In our study, 85% of our patients were using mobile phones with internet access, whereas 98% of our healthy volunteers were using mobile phones (p<0.05). While 53.5% of the patients had their mobile phones with them while they were sleeping, this rate was 83.7% in healthy volunteers (p<0.05). However, 93.9% of the healthy volunteers did not have a Wi-Fi device in their bedrooms, and this rate was 75% in the patient group (p<0.05). Conclusion: Although miRNA-30C-5p and miRNA-574-5p gene expression levels were higher in patients than in healthy volunteers, the differences were not statistically significant. Although there was no significant difference in miRNA levels, we believe that due to the higher rate of Wi-Fi device presence in bedrooms in patients compared with healthy volunteers, the effects of electromagnetic radiation on the thyroid can be reduced by paying attention to this simple change.
22 January 2025 in Molecular Imaging and Radionuclide Therapy
Relationship of Plasma Cell Infiltration Rates with 18F-FDG PET/CT Data and Hematological Parameters in Multiple Myeloma - Molecular Imaging and Radionuclide Therapy
2 January 2026 in Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Objectives: Chronic kidney disease (CKD) is a significant health issue worldwide, leading to both cardiovascular diseases and the development of end-stage chronic kidney failure. Guidelines recommend the use of serum creatinine and glomerular filtration rate (GFR) calculations as the first step in the assessment of renal function. In this study, we aimed to assess the performance of three different creatinine-based GFR estimation formulae (Chronic Kidney Disease Epidemiology Collaboration, CKD-EPI 2021; Modification of Diet in Renal Disease, MDRD; Cockcroft-Gault, CG) by comparing them to measured GFR using technetium-99m diethylene triamine penta-acetic acid ( 99m Tc-DTPA) with dual plasma sampling, a more reliable method for GFR assessment. Methods: A total of 905 patients, 433 male and 472 female, who applied for routine GFR measurement with 99m Tc-DTPA between 2012 and 2016 were included in this study. Results: The median GFR value measured by 99m Tc-DTPA using dual plasma sampling was 25 mL/min/1.73 m 2 , while the formulae based on creatinine overestimated GFR. Kappa analysis showed moderate levels of agreement in classifying CKD stages. The highest discrepancies were observed in patients with normal creatinine values. Conclusions: In older adults, serum creatinine levels and creatinine-based GFR estimation may not reliably reflect renal function due to age-related physiological changes such as decreased muscle mass and creatinine production. Nevertheless, our results suggest that the weight-corrected CG formula may be a suitable alternative to overcome these limitations in patients over 60 years of age when GFR cannot be determined by cystatin C or 99m Tc-DTPA.
Malnütrisyon oranının en yüksek olduğu hastalıklardan biri kanserdir. Bundan dolayı gerekli durumlarda beslenme tedavilerinin başlanması önerilmekte olup nutrisyonel destek oral, enteral veya parenteral yolla uygulanabilmektedir. Malignitenin kendi etkisi nedeni ile olduğu gibi kemoterapi, radyoterapi gibi tedaviler sonucunda da malnütrisyon gelişebilmektedir. Malnütrisyon nedeni ile kanser hastalarının yaklaşık olarak %20’si kaybedilmektedir. Gastrointestinal, baş boyun ve akciğer kanserleri malnütrisyon riskinin en yüksek olduğu malignitelerdir. Kanserde ve kanser tedavilerinde meydana gelen iştah kaybı, malnutrisyona ve kanser kaşeksisine sebep olmaktadır. Kanser kaşeksisi ise daha komplike ve ileri bir durumdur. Bu yüzden malnütrisyon gelişme ihtimali riski yüksek olan kanser hastaları tanı konduktan sonra kaşeksi gelişmemesi açısından düzenli olarak değerlendirilmeli, gerekli durumlarda nutrisyonel destek sağlanmalıdır.